MarketPulse — Real-Time Financial News & Market Analysis

DGRO offers low-cost dividend growth exposure with $38.37B in assets and a competitive 0.08% expense ratio, delivering strong long-term performance for income investors.

Gold prices rise due to supply constraints, boosting mining stocks over bullion. Investors favor mining equities like Hecla and Kinross for diversified commodity exposure.

Homebuilders face margin pressure from rising costs, while equipment makers and infrastructure companies benefit from strong demand and backlogs amid mixed economic signals.

Gate City Capital trimmed Peabody Energy stake by $14.15M after stock rallied 105%, reducing position to $18.11M while keeping it as fifth-largest holding.

Bensler invests $11.7M in Goldman Sachs tech-focused income ETF (GPIQ), betting on growth with income generation via covered call strategy yielding 10.1%.

Class action lawsuit filed against Smart Digital Group for allegedly failing to disclose market manipulation and fraudulent promotional activities that harmed investors between May and September 2025.

Ramaco Resources faces class action lawsuit for allegedly misrepresenting Brook Mine's operational status, failing to disclose lack of mining activity despite groundbreaking ceremony claims.

Class action lawsuit filed against Sallie Mae for allegedly concealing loan delinquency increases and overstating loss mitigation effectiveness, artificially inflating stock prices during July-August 2025.

Klarna faces class action lawsuit alleging it misrepresented loan portfolio risks and understated credit exposure in its September 2025 IPO.

REGENXBIO faces class action lawsuit alleging false statements about RGX-111 gene therapy trial results, covering securities purchased between February 2022 and January 2026.

Mereo BioPharma faces class action lawsuit over allegedly misleading disclosures about failed Phase 3 clinical trials. Investors who purchased shares between June 2023 and December 2025 may be eligible.

Class action lawsuit filed against agilon health for allegedly making false 2026 guidance claims and overstating benefits of risk reduction initiatives, affecting investors from February-August 2025.

Varonis Systems faces class action lawsuit alleging false statements about SaaS conversion capabilities artificially inflated stock prices, harming shareholders during February-October 2025.

Historical data shows S&P 500 outperformance during four-legged zodiac animal years. Year of the Horse begins Tuesday with optimistic market outlook.

J&J's lung cancer therapy Rybrevant Faspro gains FDA approval for accelerated monthly dosing, maintaining efficacy while improving patient convenience and reducing treatment burden.

Cloudflare and Mastercard partner to provide affordable, enterprise-grade cybersecurity tools for small businesses and critical infrastructure protection.

Segall Bryant & Hamill reduced its Littelfuse stake by $5.19M amid strong stock gains. The circuit protection firm benefits from AI sector demand with projected 21% revenue growth in 2026.

Compass Pathways stock surged 44% after positive Phase 3 trial results for psilocybin depression therapy. FDA application expected by end of 2024.

Gold prices surged past $5,000/oz in February 2026 with bullish forecasts to $6,100-$6,300. Major producers reported record output and increased dividends amid strong demand.

ConocoPhillips shares fell 2.2% on Tuesday due to declining oil prices and an analyst downgrade citing valuation concerns amid expected oversupply through 2026.